Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections
- 1 July 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 22 (1) , 103-107
- https://doi.org/10.1128/aac.22.1.103
Abstract
Eighteen patients with 21 serious infections were treated with ceftriaxone, 1 g intravenously every 12 h, for a mean duration of 8 days. Eighteen gram-negative and two gram-positive organisms were isolated. Sites of infection included blood (three patients), urinary tract (six patients), respiratory tract (seven patients), biliary tract (three patients), ascitic fluid (one patient), and skin (one patient). Serum, bile, and ascitic fluid concentrations of ceftriaxone were in excess of the minimal bactericidal concentration required for the infecting organism in all cases. A bacteriological response was demonstrated in 94% of the infections. A clinical response occurred in four infections from which no pathogens were recovered. In one patient, ceftriaxone failed to eradicate a peritoneal infection due to Bacteroides fragilis. In two patients, superinfection with enterococci developed both during and after therapy. Systemic tolerance to ceftriaxone was excellent.This publication has 12 references indexed in Scilit:
- Pharmacokinetics of ceftriaxone in humansAntimicrobial Agents and Chemotherapy, 1981
- Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporinJournal of Antimicrobial Chemotherapy, 1981
- In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporinAntimicrobial Agents and Chemotherapy, 1981
- Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studiesAntimicrobial Agents and Chemotherapy, 1980
- In vitro evaluation of Ro 13-9904Antimicrobial Agents and Chemotherapy, 1980
- Ro 13–9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an in vitro comparative studyJournal of Antimicrobial Chemotherapy, 1980
- In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamasesAntimicrobial Agents and Chemotherapy, 1980
- Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporinAntimicrobial Agents and Chemotherapy, 1980
- LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activityAntimicrobial Agents and Chemotherapy, 1979
- Antibacterial Activity of a New 1-Oxa Cephalosporin Compared with That of Other β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979